Cody E. Cotner
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 4
- COVID-19 and healthcare impacts 2
- Cancer survivorship and care 2
- Peptidase Inhibition and Analysis 1
-
- Palliative Care and End-of-Life Issues 3
- Clinical practice guidelines implementation 1
- Co-authors
- R. Sonali Majumdar (1 shared paper)Charalambos Solomides (1 shared paper)John Scholler (1 shared paper)Steven Μ. Albelda (1 shared paper)Ellen Puré (1 shared paper)Liang‐Chuan S. Wang (1 shared paper)Michael Antzis (1 shared paper)Laura A. Johnson (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Life (1 paper)JCO Oncology Practice (1 paper)Annals of the American Thoracic Society (1 paper)JCO Clinical Cancer Informatics (1 paper)
- Partner nations
- United StatesSlovakiaSwitzerland
In The Last Decade
Cody E. Cotner
9 papers receiving 534 citations
Cody E. Cotner's Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 464
- Immunology 183
- Cancer Research 66
- Genetics 89
- Biomedical Engineering 127
Countries citing papers authored by Cody E. Cotner
This map shows the geographic impact of Cody E. Cotner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cody E. Cotner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cody E. Cotner more than expected).
Fields of papers citing papers by Cody E. Cotner
This network shows the impact of papers produced by Cody E. Cotner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cody E. Cotner. The network helps show where Cody E. Cotner may publish in the future.
Co-authors
The 25 scholars most cited alongside Cody E. Cotner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity Hit paper breakdown → | 2013 | 515 |
| 2 | 2020 | 9 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2020 | 3 | |
| 6 | 2021 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2021 | 1 | |
| 10 | 2024 | 0 |
About Cody E. Cotner
Cody E. Cotner is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Epidemiology, General Health Professions and Pediatrics, Perinatology and Child Health, having authored 10 papers that have together received 537 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (3 papers), COVID-19 and healthcare impacts (2 papers), Cancer survivorship and care (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Clinical practice guidelines implementation (1 paper), Mycobacterium research and diagnosis (1 paper) and Patient-Provider Communication in Healthcare (1 paper). The work is most often cited by research in Oncology (464 citations), Immunology (183 citations), Cancer Research (66 citations), Genetics (89 citations) and Biomedical Engineering (127 citations). Cody E. Cotner has collaborated with scholars based in United States, Slovakia and Switzerland. Frequent co-authors include R. Sonali Majumdar, Charalambos Solomides, John Scholler, Steven Μ. Albelda, Ellen Puré, Liang‐Chuan S. Wang, Michael Antzis, Laura A. Johnson, Jing Sun and Veena Kapoor. Their work appears in journals such as Journal of Clinical Oncology, Life, JCO Oncology Practice, Annals of the American Thoracic Society and JCO Clinical Cancer Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.